- Generic name
- Tranexamic Acid
- Strength
- 250 mg/5 ml
- Dosage form
- Injection
- Manufactured by
- Advanced Chemical Industries PLC
Anaxyl Injection
About Anaxyl 250 mg/5 ml Injection
Anaxyl Injection contains tranexamic acid, an anti-fibrinolytic medicine given by injection. It is used to help control bleeding linked to excessive clot breakdown in certain medical and surgical conditions.
There are 35 brands of Tranexamic Acid listed in Bangladesh. The lowest listed price is Enclot 250 mg Capsule at ৳ 8.06 per unit.
What is Anaxyl 250 mg/5 ml Injection?
Anaxyl Injection is a product of Advanced Chemical Industries PLC. It contains tranexamic acid, which belongs to a group called anti-fibrinolytic drugs. These medicines work against the breakdown of blood clots, which is how they help limit bleeding in some situations. The injection is available in the strength 250 mg/5 ml and is given by a healthcare professional. It is used in certain bleeding conditions in medicine and around surgery. The decision to use it, and the dose and course, is made by the doctor.
Uses of Anaxyl
Anaxyl Injection is used in certain bleeding problems where excessive clot breakdown plays a part. These include some bleeding in the lungs and digestive tract, bleeding linked to certain blood and liver conditions, and bleeding during and after operations of various types. Only a doctor can decide whether this medicine is appropriate. Ask the doctor about what it is being used for in a particular case.
How to use Anaxyl
Anaxyl Injection is given by a healthcare professional, usually into a vein or a muscle. You should not give it to yourself. The doctor decides the dose, how it is given and how long treatment continues. Tell the doctor about any other medicines being taken and about any kidney problems before it is given. Ask the doctor or pharmacist if you have questions about the course of treatment.
Side effects of Anaxyl
Anaxyl Injection is generally well tolerated, but some people may notice effects such as tiredness, eye irritation, a blocked nose, itching, skin redness or a rash. Rarely, a fall in blood pressure on standing has been reported. If there are signs of an allergic reaction, treatment should be stopped and appropriate care started. Tell the doctor or nurse about any unusual symptoms during or after the injection.
Safety and precautions
Anaxyl Injection should not be used by anyone with a known allergy to tranexamic acid, a history of blood clots in arteries or veins, certain internal bleeding, or serious kidney failure. It is used with caution in milder kidney problems. Because its effects on an unborn baby are not known, it should not be given during known or suspected pregnancy. It passes into breast milk in small amounts, and an effect on the baby is considered unlikely. Always ask the doctor first about pregnancy, breastfeeding and other health conditions.
Frequently asked questions
What kind of medicine is Anaxyl Injection and what is it used for?
It is an anti-fibrinolytic injection containing tranexamic acid. It is used in certain bleeding conditions in medicine and around surgery, where excessive clot breakdown plays a part. The doctor decides whether it is suitable for a particular person.
Which medicines may interact with Anaxyl Injection?
It is incompatible with solutions containing penicillins, and thrombolytic drugs such as streptokinase and urokinase can oppose its action. Estrogen-containing medicines like oral contraceptives may raise the potential for clot formation. Mixing it directly with whole blood during transfusion should be avoided. Tell the doctor about all medicines being taken.
Is Anaxyl Injection safe in pregnancy or breastfeeding?
It should not be given during known or suspected pregnancy, because its effects on the unborn baby are not known. It passes into breast milk in small amounts, and an effect on the baby is considered unlikely. Ask the doctor before use if pregnant or breastfeeding.
Who should ask a doctor before Anaxyl Injection is used?
Anyone with a history of blood clots, kidney problems, or an allergy to tranexamic acid should tell the doctor first. People who are pregnant or breastfeeding should also check with the doctor. The doctor decides whether the injection is appropriate.
Indications
In surgery: Prophylaxis and antihemorrhagic ... Read moreIn medicine: Prophylaxis and therapy of hemophtoes, digestive hemorrhages, hemorrhagic syndromes in leukaemia, cirrhosis and hemophilia, thrombocytopenic purpura, accidents during thrombolytic therapy and transfusion.
In surgery: Prophylaxis and antihemorrhagic therapy during operations of any type and nature and particularly in pulmonary, cardiovascular and abdominal surgery and post-operative and traumatic shock.
In urology: Prophylaxis and antihemorrhagic therapy of prostatic, vesical and renal surgery. Hematurias.
In obstetrics: Prophylaxis and therapy of post-partum and puerperium hemorrhages, hemorrhagic metrophathies, functional menometrorrhagias, idiopathic or IUD(lntra uterine Device) induced menorrhagias, primitive hyperfibrinolysis (abruptio placentae, premature placenta detachment) and in cervical conization.
In otorhinolaryngology: Prophylaxis and antihemorrhagic therapy during a tonsillectomy, specialist surgery generally, epistaxis.
In stomatology: Prophylaxis and antihemorrhagic therapy during maxillofacial operations, tooth extractions.
In oncology (as supportive therapy): To promote the formation of a fibrin capsule to wall off and thereby inhibit the growth of ovarian tumors. To cause regression of ascites secondary to carcinoma. To reduce bleeding during surgical interventions.
Pharmacology
The acute toxicity of Tranexamic Acid is extremely low and chronic toxicity almost non-existent. Tranexamic Acid is well absorbed by oral route and the effect is already seen 15-30 minutes after administration. It is excreted mainly by renal route but more slowly than conventional hemostatics. These features make the Tranexamic Acid effect more lasting than those conventional hemostatics. Considerably lower single doses of Tranexamic Acid can thus be administered at greater intervals without the drug plasma levels dropping to inefficient levels of antifibrinolytic activity between one dose and the other.
Tranexamic Acid at therapeutic doses does not interfere with clotting processes and even a prolonged administration has not been seen to be accompanied by any tendency to thrombophilia.
Dosage & Administration
- The usual dose: 500-1000 mg 3 times daily.
- For prophylaxis: The mean recommended daily doses are 0.5-1 gm orally, 500 mg by the parenteral (intravenous or intramuscular) route.
- For therapy of hemorrhagic manifestations: the oral dose increases to 1-3 gm given in divided doses: in cases of particular seriousness and urgency, begin by injecting an ampoule (500 mg) slowly by intravenous route and administer the necessary subsequent oral doses.
- For prophylaxis: For every kg of body weight from 5-10 mg are orally administered daily in divided doses.
- For therapeutic purposes: The oral doses are doubled (from 10 to 20 mg/kg), while the intravenous and intramuscular treatment is begun with 10 mg/kg (=0.5 ml every 5 kg) by the slow intravenous route, continuing the oral administration up to the required dose. Where it is more convenient (e.g. in small babies) the ampoules, diluted in a little sweetened water, maybe orally administered instead of the Capsules.
Interaction
Contraindications
Side Effects
- Tranexamic Acid is generally well tolerated; there may be infrequent cases of sense of fatigue, conjunctival irritation, nasal blockage, itching, skin reddening, exanthems.
- After oral administration there may be sign of nausea, diarrhea, gastric pyrosis.
- There are rare cases of postural hypotension.
- In the case of hypersensitivity to tranexamic acid, avoid or suspend treatment and start a suitable therapy.
Pregnancy & Lactation
Precautions & Warnings
- Tranexamic Acid should be used in cases where there is hyperfibrinolysis. The prophylactic treatment must begin 24 hours before the operation and continue until 3-4 days after it.
- The therapy of hemorrhages must be prolonged for at least 24 hours after manifestations have disappeared.
- In hematuria, especially when this is not accompanied by any other hemorrhagic manifestations, reduce the doses to prevent formation of clots in the urinary tract.
- Tranexamic Acid must not be used in serious renal insufficiency or anuric syndromes and must only be used with caution in less serious renal dysfunctions.
- The administration of product requires particular care in cardiopathic and hepatopathic subjects.
Storage Conditions
Alternative brands of Tranexamic Acid
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.